PKPetr Kouba

Petr Kouba

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Petr Kouba has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Taurine inhibits apolipoprotein E4 aggregation

    by Anthony Legrand, Katerina Amruz Cerna, Sérgio M. Marques, Naina Verma, Jakub Kopko, Tereza Vanova, Madhumalar Subramanian, Aliaksandra Kursit, Jaroslav Bendl, Tomas Henek, et al.

  • Open Access

    Uncovering Functional Distant Mutations by Ultra-High-Throughput Screening of Dehalogenases

    by Hana Faldynova, David Kovar, Ankit Jain, Michaela Slanska, Marek Martinek, Andreas Jakob, Marie Sulova, Michal Vasina, Joan Planas-Iglesias, Sergio Marques, et al.

    Conformational dynamics play a central role in enzyme function by controlling substrate access and productive binding. Yet mutations that beneficially modulate these properties are difficult to identify. Here, we used ultrahigh-throughput fluorescence-activated droplet sorting (FADS) with a bulky fluorogenic substrate derived from coumarin (COU–3) to impose steric selection pressure on the haloalkane dehalogenase LinB. Screening a focused library yielded five single substitutions located 11.5–15.5 Å from the catalytic centre. Variant I138N showed a fourfold increase in catalytic efficiency toward COU–3 through reduced K M and increased k cat , associated with increased cap–domain flexibility and facilitated substrate entry. In contrast, variant P208S markedly reduced substrate inhibition and shifted specificity toward bulkier iodinated haloalkanes by reshaping its tunnel environment. Integrated kinetic and structural analyses revealed that screening with bulky substrates directs selection toward distal regions controlling substrate access and unproductive binding. These findings demonstrate that ultrahigh–throughput FADS can reveal dynamic mechanisms of enzyme adaptation that remain difficult to predict by rational design.


  • Open Access

    Isolation of structural constraints by ensemble-conditioned protein sequence design

    by Richard W. Shuai, Tianyu Lu, Subhang Bhatti, Petr Kouba, Po-Ssu Huang

    Natural sequences have long been the assumed ground truth for protein sequence design methods. But natural sequences encode more than the structural fold, carrying evolutionary history that reflects ancestry, drift, and function. Deep learning models for protein sequence design inherit this signal, achieving higher native sequence recovery but lower predicted foldability. Motivated by this trade-off, we introduce Caliby, a Potts model-based sequence design method capable of conditioning on structural ensembles. By conditioning on synthetic ensembles generated from an input backbone, Caliby samples sequences consistent with shared structural constraints while averaging out native sequence confounders. This strategy improves designability while reducing native sequence recovery, and generalizes across sequence design models. Mechanistically, designed sequences show reduced covariation between non-contacting residues and lower energetic frustration, indicating more precise structural encoding. We demonstrate experimental applicability by designing thermostable proteins, functional lanthanide binders, and soluble membrane protein variants, including a pentameric assembly confirmed by cryo-EM.


  • Quantum computing for faster enzyme discovery and engineering

    by Jiri Damborsky, Petr Kouba, Josef Sivic, Michal Vasina, David Bednar, Stanislav Mazurenko


  • Open Access

    Conditional Protein Structure Generation with Protpardelle-1c

    by Tianyu Lu, Richard Shuai, Petr Kouba, Zhaoyang Li, Yilin Chen, Akio Shirali, Jinho Kim, Po-Ssu Huang

    We present Protpardelle-1c, a collection of protein structure generative models with robust motif scaffolding and support for multi-chain complex generation under hotspot-conditioning. Enabling sidechain-conditioning to a backbone-only model increased Protpardelle-1c’s MotifBench score from 4.97 to 28.16, outperforming RFdiffusion’s 21.27. The crop-conditional all-atom model achieved 208 unique solutions on the La-Proteina all-atom motif scaffolding benchmark, on par with La-Proteina while having ~10 times fewer parameters. At 22M parameters, Protpardelle-1c enables rapid sampling, taking 40 minutes to sample all 3000 MotifBench backbones on an NVIDIA A100-80GB, compared to 31 hours for RFdiffusion.


  • Open Access

    CoVAMPnet: Comparative Markov State Analysis for Studying Effects of Drug Candidates on Disordered Biomolecules

    by Sérgio M. Marques, Petr Kouba, Anthony Legrand, Jiri Sedlar, Lucas Disson, Joan Planas-Iglesias, Zainab Sanusi, Antonin Kunka, Jiri Damborsky, Tomas Pajdla, et al.

    Computational study of the effect of drug candidates on intrinsically disordered biomolecules is challenging due to their vast and complex conformational space. Here, we developed a comparative Markov state analysis (CoVAMPnet) framework to quantify changes in the conformational distribution and dynamics of a disordered biomolecule in the presence and absence of small organic drug candidate molecules. First, molecular dynamics trajectories are generated using enhanced sampling, in the presence and absence of small molecule drug candidates, and ensembles of soft Markov state models (MSMs) are learned for each system using unsupervised machine learning. Second, these ensembles of learned MSMs are aligned across different systems based on a solution to an optimal transport problem. Third, the directional importance of inter-residue distances for the assignment to different conformational states is assessed by a discriminative analysis of aggregated neural network gradients. This final step provides interpretability and biophysical context to the learned MSMs. We applied this novel computational framework to assess the effects of ongoing phase 3 therapeutics tramiprosate (TMP) and its metabolite 3-sulfopropanoic acid (SPA) on the disordered Aβ42 peptide involved in Alzheimer's disease. Based on adaptive sampling molecular dynamics and CoVAMPnet analysis, we observed that both TMP and SPA preserved more structured conformations of Aβ42 by interacting nonspecifically with charged residues. SPA impacted Aβ42 more than TMP, protecting α-helices and suppressing the formation of aggregation-prone β-strands. Experimental biophysical analyses showed only mild effects of TMP/SPA on Aβ42 and activity enhancement by the endogenous metabolization of TMP into SPA. Our data suggest that TMP/SPA may also target biomolecules other than Aβ peptides. The CoVAMPnet method is broadly applicable to study the effects of drug candidates on the conformational behavior of intrinsically disordered biomolecules.


  • Top Cited Papers
    Open Access

    Machine Learning-Guided Protein Engineering

    by Petr Kouba, Pavel Kohout, Faraneh Haddadi, Anton Bushuiev, Raman Samusevich, Jiri Sedlar, Jiri Damborsky, Tomas Pluskal, Josef Sivic, Stanislav Mazurenko

    Recent progress in engineering highly promising biocatalysts has increasingly involved machine learning methods. These methods leverage existing experimental and simulation data to aid in the discovery and annotation of promising enzymes, as well as in suggesting beneficial mutations for improving known targets. The field of machine learning for protein engineering is gathering steam, driven by recent success stories and notable progress in other areas. It already encompasses ambitious tasks such as understanding and predicting protein structure and function, catalytic efficiency, enantioselectivity, protein dynamics, stability, solubility, aggregation, and more. Nonetheless, the field is still evolving, with many challenges to overcome and questions to address. In this Perspective, we provide an overview of ongoing trends in this domain, highlight recent case studies, and examine the current limitations of machine learning-based methods. We emphasize the crucial importance of thorough experimental validation of emerging models before their use for rational protein design. We present our opinions on the fundamental problems and outline the potential directions for future research.